Obsidian Therapeutics, Inc. (OBX): Form 8-K filed 2026-08-03

Accepted by EDGAR

2026-08-03 17:08 ET

Event date

2026-07-31

Accession no.

0001193125-26-330810

Original filing

SEC EDGAR filing index

Items reported

• Item 1.01: Entry into a Material Definitive Agreement
  The company signed a material agreement outside the ordinary course of business, or materially amended one. Typical examples are credit agreements, merger agreements, large supply or licensing contracts and financing arrangements.
• Item 2.01: Completion of Acquisition or Disposition of Assets
  The company completed the acquisition or disposition of a significant amount of assets, including a business. The report covers the date, the assets, the counterparty and the consideration.
• Item 2.02: Results of Operations and Financial Condition
  The company publicly announced results of operations or financial condition for a completed period, most often a quarterly earnings release. The release itself is usually attached as Exhibit 99.1. Information under Item 2.02 is generally "furnished" rather than "filed".
• Item 3.02: Unregistered Sales of Equity Securities
  The company sold equity securities in a transaction not registered under the Securities Act, such as a private placement, above a size threshold.
• Item 3.03: Material Modifications to Rights of Security Holders
  The rights of holders of a class of the company's securities were materially modified, for example by a charter amendment, a rights plan or a reverse stock split.
• Item 4.01: Changes in Registrant's Certifying Accountant
  The company's independent auditor resigned, declined to stand for re-appointment or was dismissed, or a new auditor was engaged. The company must disclose any disagreements or reportable events.
• Item 5.01: Changes in Control of Registrant
  A change in control of the company occurred, for example through an acquisition of a controlling stake.
• Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
  A director or a named officer (such as the CEO or CFO) left or was appointed, or certain executive compensation arrangements were adopted or changed.
• Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
  The company amended its articles of incorporation or bylaws without a shareholder vote that was previously disclosed, or changed its fiscal year.
• Item 7.01: Regulation FD Disclosure
  The company is making information public under Regulation FD, which requires broad public disclosure of material information shared with certain market participants. Investor presentations and press releases are common. Like Item 2.02, this information is generally "furnished" rather than "filed".
• Item 9.01: Financial Statements and Exhibits
  Lists the financial statements, pro forma information and exhibits filed with the report. It almost always accompanies another Item and is rarely news on its own.

Documents

This page lists what the filing reports; it does not summarize or interpret it. Read the original documents on SEC EDGAR. How to read an 8-K.